Crescent Biopharma (CBIO) EPS (Weighted Average and Diluted) (QoQ) (2013 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 26.67% |
| Sep 30, 2024 | 6.25% |
| Jun 30, 2024 | -300.00% |
| Mar 31, 2024 | 71.43% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -7.69% |
| Jun 30, 2023 | 23.53% |
| Mar 31, 2023 | 10.53% |
| Dec 31, 2022 | -18.75% |
| Sep 30, 2022 | 36.00% |
| Jun 30, 2022 | 10.71% |
| Mar 31, 2022 | 15.15% |
| Dec 31, 2021 | 2.94% |
| Sep 30, 2021 | -21.43% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 17.74% |
| Dec 31, 2015 | -23.68% |
| Sep 30, 2015 | -174.51% |
| Jun 30, 2015 | 237.84% |
| Mar 31, 2015 | 5.13% |
| Dec 31, 2014 | -11.43% |
| Sep 30, 2014 | -189.74% |
| Jun 30, 2014 | 230.00% |
| Mar 31, 2014 | 89.29% |
| Dec 31, 2013 | 6.67% |
| Sep 30, 2013 | 18.92% |
| Jun 30, 2013 | -9,350.00% |